BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2824316)

  • 21. Infection with hepatitis delta virus in patients with fulminant hepatitis B and chronic HBsAg carriers in Bulgaria.
    Naoumov NV; Gueorgiev A; Ognyanov M; Maleev A
    Hepatogastroenterology; 1986 Apr; 33(2):49-51. PubMed ID: 3721387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger.
    Cenac A; Pedroso ML; Djibo A; Develoux M; Pichoud C; Lamothe F; Trepo C; Warter A
    Am J Trop Med Hyg; 1995 Apr; 52(4):293-6. PubMed ID: 7537942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrahepatic expression of HBcAg and delta antigen in anti-HBe positive HBsAg carriers with acute exacerbation or chronic active liver disease.
    Chu CM; Liaw YF; Sheen IS; Chen TJ
    J Med Virol; 1990 Mar; 30(3):181-6. PubMed ID: 2341834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence of anti-delta antibodies in HBsAg carriers].
    Söyletir G; Babacan F; Göral M; Can A
    Mikrobiyol Bul; 1989 Apr; 23(2):97-101. PubMed ID: 2626106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus replication in acute hepatitis B, acute hepatitis B virus-hepatitis delta virus coinfection and acute hepatitis delta superinfection.
    Genesca J; Jardi R; Buti M; Vives L; Prat S; Esteban JI; Esteban R; Guardia J
    Hepatology; 1987; 7(3):569-72. PubMed ID: 3570167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serological markers of hepatitis B virus and hepatitis D virus infections in Greek adults with primary hepatocellular carcinoma.
    Tassopoulos NC; Theodoropoulos G; Sjogren MH; Engle R; Purcell RH
    Infection; 1989; 17(1):17-9. PubMed ID: 2537800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delta infection in patients and HBsAg carriers.
    Ketiladze ES; Vyazov SO; Chernovetsky MA; Mikhailov MI; Bugayeva NP; Kozlova TP
    Prog Clin Biol Res; 1987; 234():461-6. PubMed ID: 3628413
    [No Abstract]   [Full Text] [Related]  

  • 28. [The return of the hepatitis delta virus].
    Zoutendijk R; de Jonge PJ; de Man RA
    Ned Tijdschr Geneeskd; 2016; 160():D70. PubMed ID: 27405575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis D virus infection in liver tissues of patients with hepatitis B in China.
    Hao LJ; Li L; Zhang YY; Song PH
    Chin Med J (Engl); 1992 Mar; 105(3):204-8. PubMed ID: 1395839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
    Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the hepatitis delta virus in acute hepatitis and in chronic liver disease in Greece.
    Hadziyannis SJ; Papaioannou C; Alexopoulou A
    Prog Clin Biol Res; 1991; 364():51-62. PubMed ID: 2020721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis D virus (delta agent) superinfection in an endemic area of hepatitis B infection: immunopathologic and serologic findings.
    Lee SD; Wang JY; Wu JC; Tsai YT; Lo KJ; Lai KH; Tsay SH; Govindarajan S
    Scand J Infect Dis; 1987; 19(2):173-7. PubMed ID: 3616486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The intrahepatic expression of the hepatitis B virus in chronic delta hepatitis].
    Ramalho F; Velosa J; Costa A; Baptista A; de Moura MC
    Acta Med Port; 1993 May; 6(5):187-91. PubMed ID: 8337951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study on delta virus infection and its clinical impact in Iran.
    Rezvan H; Forouzandeh B; Taroyan S; Fadaiee S; Azordegan F
    Infection; 1990; 18(1):26-8. PubMed ID: 2155876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delta infection in asymptomatic carriers of hepatitis B surface antigen: low prevalence of delta activity and effective suppression of hepatitis B virus replication.
    Chen PJ; Chen DS; Chen CR; Chen YY; Chen HM; Lai MY; Sung JL
    Hepatology; 1988; 8(5):1121-4. PubMed ID: 3417233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.
    Craxì A; Raimondo G; Longo G; Giannuoli G; De Pasquale R; Caltagirone M; Patti S; Squadrito G; Pagliaro L
    Gut; 1984 Nov; 25(11):1288-90. PubMed ID: 6500367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of wildtype and pre-C HBV variants in HBsAg/anti-HBe positive carriers with chronic hepatitis delta virus infection.
    Santantonio T; Jung MC; Monno L; Milella M; Iacovazzi T; Pastore G; Will H
    Prog Clin Biol Res; 1993; 382():235-42. PubMed ID: 8502687
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features of hepatitis D.
    Farci P; Niro GA
    Semin Liver Dis; 2012 Aug; 32(3):228-36. PubMed ID: 22932971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.